1. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup. Issue 8 (August 2022) Authors: Vergote, Ignace; Gonzalez-Martin, Antonio; Lorusso, Domenica; Gourley, Charlie; Mirza, Mansoor Raza; Kurtz, Jean-Emmanuel; Okamoto, Aikou; Moore, Kathleen; Kridelka, Frédéric; McNeish, Iain; Reuss, Alexander; Votan, Bénédicte; du Bois, Andreas; Mahner, Sven; Ray-Coquard, Isabelle; Kohn, Elise C; ... Journal: Lancet oncology Issue: Volume 23:Issue 8(2022) Page Start: e374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer. (January 2017) Authors: Marth, Christian; Vergote, Ignace; Scambia, Giovanni; Oberaigner, Willi; Clamp, Andrew; Berger, Regina; Kurzeder, Christian; Colombo, Nicoletta; Vuylsteke, Peter; Lorusso, Domenica; Hall, Marcia; Renard, Vincent; Pignata, Sandro; Kristeleit, Rebecca; Altintas, Sevilay; Rustin, Gordon; Wenham, Rob... Journal: European journal of cancer Issue: Volume 70(2017) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV). Issue 4 (5th March 2020) Authors: Rohr, Irena; Alavi, Sara; Richter, Rolf; Keller, Maren; Chekerov, Radoslav; Oskay-Özcelik, Gülten; Heinrich, Michaela; Taskiran, Cagatay; Joly, Florence; Berger, Regina; du Bois, Andreas; Gornjec, Andreja; Vergote, Ignace; Achimas-Cadariu, Patriciu; Lorusso, Domenica; Maenpaa, Johanna; Sehouli, J... Journal: International journal of gynecological cancer Issue: Volume 30:Issue 4(2020) Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial. (October 2022) Authors: González-Martín, Antonio; Desauw, Christophe; Heitz, Florian; Cropet, Claire; Gargiulo, Piera; Berger, Regina; Ochi, Hiroyuki; Vergote, Ignace; Colombo, Nicoletta; Mirza, Mansoor R.; Tazi, Youssef; Canzler, Ulrich; Zamagni, Claudio; Guerra-Alia, Eva M.; Levaché, Charles B.; Marmé, Frederik; Bazan... Journal: European journal of cancer Issue: Volume 174(2022) Page Start: 221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer. Issue 7 (15th August 2019) Authors: Lorusso, Domenica; Hilpert, Felix; González Martin, Antonio; Rau, Joern; Ottevanger, Petronella; Greimel, Elfriede; Lück, Hans-Joachim; Selle, Frédéric; Colombo, Nicoletta; Kroep, Judith R; Mirza, Mansoor R; Berger, Regina; Pardo, Beatriz; Grischke, Eva-Maria; Berton-Rigaud, Dominique; Martinez-G... Journal: International journal of gynecological cancer Issue: Volume 29:Issue 7(2019) Page Start: 1141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer. Issue 7 (September 2019) Authors: Lorusso, Domenica; Hilpert, Felix; González Martin, Antonio; Rau, Joern; Ottevanger, Petronella; Greimel, Elfriede; Lück, Hans-Joachim; Selle, Frédéric; Colombo, Nicoletta; Kroep, Judith R; Mirza, Mansoor R; Berger, Regina; Pardo, Beatriz; Grischke, Eva-Maria; Berton-Rigaud, Dominique; Martinez-G... Journal: International journal of gynecological cancer Issue: Volume 29:Issue 7(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001. Issue 1 (19th November 2021) Authors: Marth, Christian; Tarnawski, Rafal; Tyulyandina, Alexandra; Pignata, Sandro; Gilbert, Lucy; Kaen, Diego; Rubio, M Jesús; Frentzas, Sophia; Beiner, Mario; Magallanes-Maciel, Manuel; Farrelly, Laura; Choi, Chel Hun; Berger, Regina; Lee, Christine; Vulsteke, Christof; Hasegawa, Kosei; Braicu, Elena ... Journal: International journal of gynecological cancer Issue: Volume 32:Issue 1(2022) Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The N-Terminally Truncated p53 Isoform Δ40p53 Influences Prognosis in Mucinous Ovarian Cancer. Issue 3 (1st March 2012) Authors: Hofstetter, Gerda; Berger, Astrid; Berger, Regina; Zorić, Arijana; Braicu, Elena I.; Reimer, Daniel; Fiegl, Heidi; Marth, Christian; Zeimet, Alain G.; Ulmer, Hanno; Moll, Ute; Zeillinger, Robert; Concin, Nicole Journal: International journal of gynecological cancer Issue: Volume 22:Issue 3(2012) Page Start: 372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗